Company page

Scancell Holdings Plc

Scancell Holdings Plc is a public company listed on the UK market under the ticker SCLP, with a market capitalization of approximately £284.36 million. The company is focused on developing innovative immunotherapies for the treatment of cancer. Scancell aims to advance its proprietary technologies to improve patient outcomes in oncology.